You are here

Article Text

Article menu
Download PDFPDF
Controversy
Influenza vaccine
  1. V A Pai,
  2. B V Pai
  1. Royal Manchester Children’s Hospital; St James University Hospital, Leeds, UK
  1. Correspondence to:
    Dr V A Pai, 34 Thorne Lane, Roundhay, Leeds LS8 INF, UK;
    binapai{at}hotmail.com

https://doi.org/10.1136/adc.88.8.665

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Where do we stand?

    In the handbook Immunisation against infectious diseases (Green Book) published by HMSO in 1996,1 influenza vaccine has been recommended for the following categories in children:

    • Chronic cardiorespiratory conditions, including asthma

    • Diabetes

    • Chronic kidney problems

    • Diseases or treatments affecting the immune system

    • Chronic debilitating conditions.

    The reason for giving influenza vaccine is that influenza can cause considerable morbidity and mortality in the above mentioned categories. According to the Public Health Laboratory website, influenza vaccine uptake is 10–12% in the <65 year age group (no separate figure for the paediatric age group).

    Diabetes and asthma form a large part of paediatric practice, and the incidence of …

    View Full Text